| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/23/2008 | WO2008127682A2 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 10/23/2008 | WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient |
| 10/23/2008 | WO2008126732A1 Fused bicyclic heteroaryl derivatives |
| 10/23/2008 | WO2008125004A1 Use of 21 (s) argatroban for treating thrombosis and inhibiting platelet aggregation |
| 10/23/2008 | WO2008107362A3 Stabiliser and inhibitors of factor vii |
| 10/23/2008 | WO2006118488A3 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions |
| 10/23/2008 | US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 10/23/2008 | US20080262027 5Z)-2-[(2,6-Dichlorophenyl)amino]-5-{[3-(4-morpholinyl)-6-quinoxalinyl]methylidene}-1,3-thiazol-4(5H)-one; inhibiting hYAK3 proteins; autoimmunity, HIV, cancer, drug-induced anemias, myelodysplastic syndrome, aplastic anemia myelosuppression, cytopenia |
| 10/23/2008 | US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 10/23/2008 | US20080261974 Novel Chemical Compounds |
| 10/23/2008 | US20080261951 Condensed azepines as vasopressin agonists |
| 10/23/2008 | US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds |
| 10/23/2008 | US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 10/23/2008 | US20080261902 Pharmaceutical composition containing polydatin and its application |
| 10/23/2008 | US20080261886 For preventing and/or treating bleeding episodes |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins |
| 10/23/2008 | US20080260874 Nutraceutical; crushed maca aqueous ethanol extract; food and beverage product, perfume and cosmetic, or pharmaceutical; ameliorate cold sensation, numbness, pains and other skin symptoms, as well as frostbites, chilblains and chaps |
| 10/23/2008 | US20080260861 Modulating Lymphatic Function |
| 10/23/2008 | US20080260858 Universal Procoagulant |
| 10/23/2008 | US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification |
| 10/23/2008 | US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia |
| 10/23/2008 | US20080260752 Prevention and reduction of blood loss |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | CA2684075A1 Providing hemostasis in anticoagulated blood by using zeolites |
| 10/23/2008 | CA2683793A1 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 10/23/2008 | CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1982990A1 Cytokine receptor common gamma chain like |
| 10/22/2008 | EP1982984A2 Tricyclic thrombin receptor antagonists |
| 10/22/2008 | EP1982732A2 Factor VII or VIIA-like molecules |
| 10/22/2008 | EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents |
| 10/22/2008 | EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 10/22/2008 | EP1888092B1 Medicament made from laminarine or oligolaminarines for treatment of septicemia and septic shock |
| 10/22/2008 | EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 10/22/2008 | EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 10/22/2008 | EP1404349B1 Fat-binding polymers |
| 10/22/2008 | CN101291949A Aptamers comprising arabinose modified nucleotides |
| 10/22/2008 | CN101291686A Activated factor X(FXa) stimulants as new antihemorrhagic agents for topical use |
| 10/22/2008 | CN101289510A Anti-CD40 monoclonal antibody |
| 10/22/2008 | CN101289505A Bone marrow regeneration regulatory protein BRRG-2, encoding gene thereof and uses thereof |
| 10/22/2008 | CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method |
| 10/22/2008 | CN101288703A Trotter-7 soup for treating essential thrombocytopenia |
| 10/22/2008 | CN101288688A Chinese medicinal preparation for treating headache due to deficiency of blood |
| 10/22/2008 | CN101288680A Preparation method of instant tuckahoe granule |
| 10/22/2008 | CN101288665A Medicine containing alkannin compound as active component |
| 10/22/2008 | CN101288656A Spironolactone sustained-release drop pills and preparation method thereof |
| 10/22/2008 | CN101288475A Production method of flavor panax ginseng |
| 10/22/2008 | CN101288473A Buthus martensi karsch beauty treatment health-care liquor and extraction method |
| 10/22/2008 | CN101288472A Preparation method of Buthus martensi karsch beauty treatment health-care wine |
| 10/22/2008 | CN101288471A Buthus martensi karsch beauty treatment health-care wine |
| 10/22/2008 | CN100427609C Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 10/22/2008 | CN100427504C TNF alpha high-affinity chimeric antibody and use thereof |
| 10/22/2008 | CN100427081C Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 10/21/2008 | US7439342 Thrombopoietin mimetics |
| 10/21/2008 | CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 10/21/2008 | CA2247998C Fragments of cr1 and their use |
| 10/21/2008 | CA2205347C Lazaroids-based compositions and method for preventing adhesion formation using the same |
| 10/16/2008 | WO2008123093A1 Agent for prevention or treatment of iron overload |
| 10/16/2008 | WO2008123017A1 Novel diamide derivative |
| 10/16/2008 | WO2008096268A3 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery |
| 10/16/2008 | WO2008009634A3 Factor viia analogues with increased activity for treating thrombocytopenia |
| 10/16/2008 | WO2007134813B1 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255121 Combination Drug for Treating Autoimmune Disease |
| 10/16/2008 | US20080255111 (4'-{[2-(tert-Butoxycarbonyl)-3-hydroxy-4-(trifluoromethyl)benzyl]oxy}-1,1'-biphenyl-4-yl)acetic acid; vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, blood coagulation diseases |
| 10/16/2008 | US20080255028 Collagen Receptor I-Domain Binding Modulators |
| 10/16/2008 | US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE |
| 10/16/2008 | US20080254147 Composition comprising clay as the active ingredient is administered to stop bleeding wound; type A or B hemophilia or von Willebrand disease |
| 10/16/2008 | US20080254146 Method of providing hemostasis in anti-coagulated blood |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254036 Contains [2-({4-[(dimethylamino)iminomethyl]phenyl}carbonylamino)-5-methoxyphenyl]-N-(5-chloro(2-pyridyl))carboxamide (betrixaban) and antiplatelet agent for treatment of thrombosis; kits |
| 10/16/2008 | US20080254016 Composition For Increasing Anti-Oxidation Activity In Blood |
| 10/16/2008 | US20080253992 Using hydrophobic interaction chromatography to recover therapeutic fusion protein for use in treatment of injuries associated with ischemia, trauma, inflammation and contact with toxic substances |
| 10/15/2008 | EP1980246A1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 10/15/2008 | EP1567112B1 THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS |
| 10/15/2008 | EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 10/15/2008 | CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds |
| 10/15/2008 | CN101284877A Recombinant target fusion protein of antithrombin activity and anti-platelet aggregation and preparation method |
| 10/15/2008 | CN101284838A Ethylene imine derivates with thienopyridine, preparation method and applications thereof |
| 10/15/2008 | CN101284781A 4-position acylated shikimic acid or low-carbon alcohol ester thereof, preparation and applications thereof |
| 10/15/2008 | CN101284780A 5-position acylated shikimic acid or low-carbon alcohol ester thereof, preparation and applications thereof |
| 10/15/2008 | CN101284123A Yanghe decoction oral formulations and preparation method thereof |
| 10/15/2008 | CN101284105A Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease |
| 10/15/2008 | CN101284079A Chinese medicinal composition for curing the impotence and impairment of qi and blood |
| 10/15/2008 | CN101284053A Multifunctional compound medicine formulation |
| 10/15/2008 | CN101284046A Thrombus clear health soft capsules |
| 10/15/2008 | CN101284029A Pain relieving, hemostasia and antipruritic drug powder |
| 10/15/2008 | CN101284003A Medicinal composition containing andrographolide derivatives and preparation method thereof and application |
| 10/15/2008 | CN101283997A Application of bromine phenolic compound in preparing the medicine for curing the ischemic cardio-vascular and cerebrovascular diseases |
| 10/15/2008 | CN100425702C Lentiviral triplex DNA, and vectors and recombinant cells contg. same |
| 10/15/2008 | CN100425592C Indole derivatives |
| 10/15/2008 | CN100425283C Stable pharmaceutical composition comprising erythropoietin |
| 10/15/2008 | CN100425281C Technique for preparing injection of protein polyeptide |
| 10/15/2008 | CN100425252C Medicine for treating leukopenia |
| 10/14/2008 | US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 10/14/2008 | US7435795 Stabilized hemoglobin solutions |
| 10/14/2008 | US7435747 Guanidine and amidine derivatives as factor Xa inhibitors |